Chemical Angel Network - aVenture Asset Manager Research
Location
Houston, TX, US
Founded
2012
Chemical Angel Network focuses on early-stage investments within the chemical industry, primarily targeting seed and Series A rounds. The network aims to foster economic development by helping emerging companies grow to profitability or scale to attract venture capital. They provide a platform for accredited angel investors to source and vet quality investment opportunities, ensuring that promising startups receive both financial capital and experienced mentorship.
Notable portfolio companies include Amplified Sciences, Cari Health, Intrommune Therapeutics, RealSeq Biosciences, and Zylo Therapeutics. The network is driven by a mission to connect investors with high-potential ventures, offering not just funding but also educational resources and advisory services. This holistic approach helps startups navigate early growth challenges and positions them for long-term success in the chemical industry.
Chemical Angel Network - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies5
Current Portfolio Count5
Top Investment Stages
Seed3 (60.0%)
Series A2 (40.0%)
Stage Mix
Seed 60%Series A 40%
Concentration shown as share of disclosed investments by stage.